Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01876706 · ClinicalTrials.gov registry record · NA
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
A NA study, sponsored by NeoTract.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT01876706 is a NA study that has completed, run by NeoTract. The registered enrollment target is 51 participants.
The verdict
NCT01876706, a NA study, has completed, sponsored by NeoTract.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate procedure tolerability and surgical recovery following the UroLift® system procedure when conducted with local anesthesia in subjects with symptomatic benign hyperplasia (BPH). Primary effectiveness will be achieved by looking at the Quality of Recovery Visual Analog Scale (QoR VAS) by the one month follow-up visit.
Interventions
- DEVICE UroLift® System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-09-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01876706
The ClinicalTrials.gov registry entry for NCT01876706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NeoTract, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which UroLift® System is the first listed.
NCT01876706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01876706 about?
NCT01876706 is a clinical study titled "UroLift System TOlerability and ReCovery When Administering Local Anesthesia". The purpose of the study is to evaluate procedure tolerability and surgical recovery following the UroLift® system procedure when conducted with local anesthesia in subjects with symptomatic benign hyperplasia (BPH). Primary effectiveness will be achieved by looking at the Quality of Recovery Visual...
What is the current status of trial NCT01876706?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2013-04. Estimated completion is 2018-09-04.
What interventions are being tested in trial NCT01876706?
The interventions under investigation include: UroLift® System (DEVICE).
Who is sponsoring clinical trial NCT01876706?
This trial is sponsored by NeoTract, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.